The European Commission approved a dosing schedule for Bristol-Myers Squibb’s Opdivo (nivolumab) as adjuvant treatment in adult melanoma patients with lymph node involvement or metastatic disease who have undergone complete resection.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
